Concepedia

David S. Boss

DS

16

Publications

5.6K

Citations

13

H-Index

2005

Active since

Affiliations

The Netherlands Cancer Institute(Current)

Utrecht University

Oncode Institute

Institute of Cancer Research

Pfizer (United States)

David S. Boss is an author at The Netherlands Cancer Institute specializing in medicine, cancer therapeutics, and oncology.

Top concepts

Publications per year

2005–2017

16

Publications

16

Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from <i>BRCA</i> Mutation Carriers

Peter C.C. Fong, David S. Boss, Timothy A. Yap et al. · New England Journal of Medicine · 2009 · 3.6K citations · Full text

Poly(ADP)-Ribose Polymerase Inhibition: Frequent Durable Responses in <i>BRCA</i> Carrier Ovarian Cancer Correlating With Platinum-Free Interval

Peter C.C. Fong, Timothy A. Yap, David S. Boss et al. · Journal of Clinical Oncology · 2010 · 984 citations · Full text

A phase I study of E7080, a multitargeted tyrosine kinase inhibitor, in patients with advanced solid tumours

David S. Boss, Hilary Glen, Jos H. Beijnen et al. · British Journal of Cancer · 2012 · 185 citations · Full text

, , +6

Phase I Dose-Escalation Study of the Pan-HER Inhibitor, PF299804, in Patients with Advanced Malignant Solid Tumors

Pasi A. Jänne, David S. Boss, D. Ross Camidge et al. · Clinical Cancer Research · 2011 · 180 citations · Full text

Clinical evaluation of AZD1152, an i.v. inhibitor of Aurora B kinase, in patients with solid malignant tumors

David S. Boss, Petronella O. Witteveen, J. van der Sar et al. · Annals of Oncology · 2010 · 107 citations · Full text

Rows per page

1–5 of 16